| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/00000542-199310000-00023 |
| P698 | PubMed publication ID | 8214760 |
| P2093 | author name string | Kharasch ED | |
| Thummel KE | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | isoflurane | Q413918 |
| sevoflurane | Q419394 | ||
| P1104 | number of pages | 13 | |
| P304 | page(s) | 795-807 | |
| P577 | publication date | 1993-10-01 | |
| P1433 | published in | Anesthesiology | Q2012635 |
| P1476 | title | Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane. | |
| P478 | volume | 79 |
| Q57302808 | 3 The pharmacology of the cytochrome P450 enzyme system |
| Q64922947 | Alcoholic Liver Disease: Alcohol Metabolism, Cascade of Molecular Mechanisms, Cellular Targets, and Clinical Aspects. |
| Q33870250 | Alcoholic liver disease: new insights in pathogenesis lead to new treatments |
| Q51483421 | Analytical toxicology of fluorinated inhalation anaesthetics. |
| Q40768698 | Biologically stable [(18)F]-labeled benzylfluoride derivatives |
| Q29041907 | CYP-specific bioactivation of four organophosphorothioate pesticides by human liver microsomes. |
| Q51475078 | Clinical pharmacokinetics of sevoflurane. |
| Q38082475 | Colorectal cancer: a researcher's perspective of the molecular angel's gone eccentric in the Vale of Kashmir |
| Q36837622 | Colorectal cancer: molecular mutations and polymorphisms |
| Q90536663 | Cytochrome P450 2E1 and its roles in disease |
| Q37808272 | Cytochrome P450-mediated hepatic metabolism of new fluorescent substrates in cats and dogs |
| Q34369012 | Desflurane. A review of its pharmacodynamic and pharmacokinetic properties and its efficacy in general anaesthesia |
| Q33754400 | Designing safer chemicals: predicting the rates of metabolism of halogenated alkanes |
| Q34304330 | Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids |
| Q35825142 | Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans |
| Q37715233 | Distribution of genetic polymorphisms of genes encoding drug metabolizing enzymes & drug transporters - a review with Indian perspective |
| Q79200629 | Drug interactions and the anesthesiologist |
| Q35879020 | Drug interactions with St John's wort : mechanisms and clinical implications |
| Q36172457 | Dual-Modality Optical/PET Imaging of PARP1 in Glioblastoma |
| Q33704279 | Effect of Animal Condition and Fluvoxamine on the Result of [(18)F]N-3-Fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl) Nortropane ([(18)F]FP-CIT) PET Study in Mice |
| Q51544933 | Effect of chronic anesthesia on the drug-metabolizing enzyme system and heme pathway regulation. |
| Q33612958 | Effect of cigarette smoking on the washout time of sevoflurane anesthesia |
| Q38516506 | Effect of sevoflurane anesthesia on the severity of renal histopathologic changes in rabbits pretreated with gentamicin: A controlled, investigator-blinded, experimental study. |
| Q36166535 | Effect of the severity of liver dysfunction on the minimum alveolar concentration of sevoflurane responding to an electronic stimulation in cirrhotic patients |
| Q34347573 | Effects of anesthetics, sedatives, and opioids on ventilatory control |
| Q43058961 | Evaluation of antioxidant parameters in rats treated with sevoflurane |
| Q35773714 | Exceptionally stable fluorous emulsions for the intravenous delivery of volatile general anesthetics |
| Q44017429 | Exposure of neonatal mice to Sevoflurane may induce male germ cell apoptosis in testicular tissue after puberty |
| Q35545603 | Fluorinated COX-2 inhibitors as agents in PET imaging of inflammation and cancer |
| Q51916911 | Genetic polymorphism analysis of cytochrome P4502E1 (CYP2E1) in Chinese Han populations from four different geographic areas of Mainland China. |
| Q34273450 | Genetic polymorphisms in CYP2E1: association with schizophrenia susceptibility and risperidone response in the Chinese Han population. |
| Q35129127 | Halogenated inhalational anaesthetics |
| Q51540322 | Halothane Inhalation Inhibits the Metabolism of Chlorzoxazone, a Substrate for CYP2E1, in Rabbits |
| Q28610007 | Identification of the enzyme responsible for oxidative halothane metabolism: implications for prevention of halothane hepatitis |
| Q41172369 | Idiosyncratic drug reactions. Metabolic bioactivation as a pathogenic mechanism |
| Q34857055 | In vivo magnetic resonance imaging to detect biliary excretion of 19F-labeled drug in mice |
| Q47257594 | Inhaled anesthetic agent sedation in the ICU and trace gas concentrations: a review |
| Q42526010 | Inhibition of cytochrome P450 2E1 by propofol in human and porcine liver microsomes |
| Q30406048 | Management of nontuberculous mycobacterial infection in the elderly |
| Q26781407 | Methods to Increase the Metabolic Stability of (18)F-Radiotracers |
| Q34382133 | Proton nuclear magnetic resonance and pattern recognition analysis of liver extracts from rats under different anesthetics |
| Q33626578 | Radiochemistry on electrodes: Synthesis of an 18F-labelled and in vivo stable COX-2 inhibitor |
| Q51595700 | Relationship of Inspired Anesthetic Concentration to Plasma Concentration and Urinary Excretion of Sevoflurane Metabolites in Rats |
| Q51595707 | Renal Function and Serum Fluoride Concentrations in Patients with Stable Renal Insufficiency After Anesthesia with Sevoflurane or Enflurane |
| Q48589026 | Renal safety and extrahepatic defluorination of sevoflurane in hepatic transplantations |
| Q36475153 | Role of CYP2E1 genotypes in susceptibility to colorectal cancer in the Kashmiri population. |
| Q34290155 | Sevoflurance: approaching the ideal inhalational anesthetic. a pharmacologic, pharmacoeconomic, and clinical review. |
| Q71361532 | Sevoflurane |
| Q34389033 | Sevoflurane. A review of its pharmacodynamic and pharmacokinetic properties and its clinical use in general anaesthesia |
| Q47722095 | Single-dose disulfiram does not inhibit CYP2A6 activity |
| Q35764861 | Spectrum and subcellular determinants of fluorinated anesthetic-mediated proximal tubular injury. |
| Q34657381 | Sucralose, a synthetic organochlorine sweetener: overview of biological issues |
| Q28481380 | Systematic functional characterization of cytochrome P450 2E1 promoter variants in the Chinese Han population |
| Q56474940 | The Role of Active Metabolites in Drug Toxicity |
| Q35104982 | The cytochrome P-450 isoenzyme CYP2E1 in the biological processing of industrial chemicals: consequences for occupational and environmental medicine |
| Q40109935 | The effects of N-acetylcysteine on hepatic function during isoflurane anaesthesia for laparoscopic surgery patients |
| Q33832797 | The role of new anesthetic agents |
| Q36801501 | Tobacco control for anesthesiologists |
| Q46466856 | Urinary sevoflurane and hexafluoro-isopropanol as biomarkers of low-level occupational exposure to sevoflurane |
| Q36851934 | Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions |
Search more.